Literature DB >> 4018129

Histamine-mediated acetylcholine release in the guinea-pig ileum.

R Rubinstein, S Cohen.   

Abstract

The isometric contraction induced by histamine in guinea-pig ileum longitudinal muscle was biphasic in Krebs ([Ca]: 3.36 mM) but monophasic in Tyrode solution ([Ca]: 1.80 mM). The late phase (histamine: 20-400 nM) was common to the two solutions but the early phase (histamine: 2-20 nM) was observed only in Krebs solution. This early phase could be blocked with atropine (0.01-0.2 microM), morphine (0.1, 1 microM), adenosine (5, 20 microM) and tetrodotoxin (0.3 microM) without affecting the late phase. Washout of morphine or adenosine was fast. Neostigmine (100 nM) greatly potentiated the effect of histamine (4 nM) in the early phase, the muscle undergoing almost maximum contraction but also reversible desensitization to doses of histamine less than or equal to 20 nM for as long as 40 min after washout. Beyond this concentration, the preparation responded to increasing doses of histamine as observed in the late phase. It is concluded that low concentrations of histamine that have no observable direct effect on muscle contractility release acetylcholine in the presence of [Ca] 3.36 mM, the early phase being entirely due to release of endogenous acetylcholine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018129     DOI: 10.1016/0014-2999(85)90763-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Effects of histamine H1-, H2- and H3-receptor selective drugs on the mechanical activity of guinea-pig small and large intestine.

Authors:  R Leurs; M M Brozius; M J Smit; A Bast; H Timmerman
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

2.  Pharmacological investigation into the effects of histamine and histamine analogues on guinea-pig and rat colon in vitro.

Authors:  M J Aguilar; F J Morales-Olivas; E Rubio
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.